Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2000, p. 3456-3460, Vol. 44, No. 12
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Structural and Topological Differences between a
Glycopeptide-Intermediate Clinical Strain and Glycopeptide-Susceptible
Strains of Staphylococcus aureus Revealed by Atomic
Force Microscopy
Susan
Boyle-Vavra,1,*
Jongin
Hahm,2
S. J.
Sibener,2 and
Robert
S.
Daum1
Department of
Pediatrics1 and Department of Chemistry
and The James Franck Institute,2 The
University of Chicago, Chicago, Illinois 60637
Received 2 May 2000/Returned for modification 18 July 2000/Accepted 15 September 2000
 |
ABSTRACT |
Novel cell surface topography was revealed on cocci from a
glycopeptide-intermediate Staphylococcus aureus (GISA)
clinical strain by using atomic force microscopy. The GISA isolate and its revertant had two parallel circumferential surface rings. One
equatorial surface ring was observed in control strains. In vancomycin-susceptible strains, additional rings were formed in the
presence of vancomycin. Ring depth measurements also revealed striking
differences between the GISA strain and susceptible strains grown with
or without vancomycin.
 |
TEXT |
The emerging problem of intermediate
resistance to the glycopeptide antibiotic vancomycin in
Staphylococcus aureus isolates (25) has raised
concern, since few therapeutic options remain for treatment.
Glycopeptide antibiotics kill gram-positive bacteria by interfering
with the synthesis of peptidoglycan (reviewed in reference
1a). We reasoned that the identification of cell
surface alterations associated with the resistance phenotype could lead to an improved understanding of the mechanism of resistance. Studies performed to date to describe the morphology of untreated and vancomycin-treated vancomycin-resistant S. aureus cells
(7, 8, 13, 20-22) have been limited to the examination of
ultrathin cross-sections of fixed bacteria using transmission electron
microscopy. Characterization of the cell surface topology of
glycopeptide-resistant isolates is still lacking.
Atomic force microscopy (AFM), a scanning probe microscopy
technique recently used to elucidate the detailed nanoscale
structure of soft polymers (11, 12), has recently been used
to elucidate the detailed structure of biological surfaces
(15), including the cell walls of bacteria (3, 4,
26). The advantages of AFM over alternative techniques such as
scanning electron microscopy include enhanced resolution, the ability
to measure surface topographic features, and sample preparation lacking
harsh chemical treatments that might form artifacts.
Using contact mode AFM, we characterized the surface topology of cells
from a glycopeptide intermediate-resistant S. aureus (GISA)
isolate (strain NJ) (5, 6, 23). For strain NJ, the MIC of
vancomycin is intermediate according to the guidelines published by the
National Committee for Clinical Laboratory Standards (18). A
vancomycin-susceptible revertant of that isolate (NJ[P15]) (2) was also studied, as well as two vancomycin-susceptible control strains, RN4220 (14) and methicillin-resistant
S. aureus (MRSA) isolate 6/3 8N, which was obtained from our
collection (24). The effects of vancomycin induction on
surface topology were also examined.
Bacteria were collected from brain heart infusion agar (BHIA) and
suspended in 0.85% saline to an A600 of 1.0. A
5.0-µl drop of the bacterial suspension was applied to a small glass
chip (4 by 4 mm2) and allowed to air dry. The subinhibitory
concentration of vancomycin for each strain was determined by passaging
on a series of BHIA plates containing vancomycin (1 to 8 µg/ml). AFM
imaging was performed in contact mode with a Topometrix Discoverer AFM
(Thermomicroscopes, Sunnyvale, Calif.) equipped with a 75-µm scanner
and a silicon nitride cantilever probe (spring constant of 0.032 N/m).
The cantilever probe exerted a constant force of 1 nN on the surfaces
of the bacterial cells. The same cantilever tip was used for all
experiments; however, force calibration measurements of the cantilever
probe were performed prior to the scanning of each new sample.
When samples were scanned over a large area, cocci were arranged in
grapelike clusters, the morphology typical of staphylococci (Fig.
1). The mean cell diameter was consistent
with that expected for S. aureus (1 µm). The cell surface
of the cocci appeared relatively smooth in texture, except for an
occasional protrusion. Viewing cells of strains RN4220 and 6/3 8N over
a small scanning area revealed a single equatorial ring on the surface
of each cell (Fig. 2a). This ring likely
marks the septal plane of division between future daughter cells.
Tetrads of undivided cells were occasionally seen with their rings
forming two perpendicular lines, as in a cross-like structure (Fig.
2b), a morphology demonstrated previously by scanning electron
microscopic imaging of freeze-etched samples (9). Such
images illustrate S. aureus division septa forming normally
at right angles (10).

View larger version (173K):
[in this window]
[in a new window]
|
FIG. 1.
AFM image of GISA strain NJ showing cocci arranged in
grapelike clusters. Scanning area, 25 by 25 µm.
|
|

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 2.
AFM images of cocci from vancomycin-susceptible control
strains. (a) Vancomycin-susceptible MRSA strain 6/3 8N showing a
typical view of a single circumferential ring (arrow). (b) Undivided
tetrad of cells of strain RN4220 with the perpendicular arrangement of
circumferential rings forming a cross-like structure (arrow). (c) Cells
of vancomycin (1 µg/ml)-treated, vancomycin-susceptible MRSA strain
6/3 8N illustrating an equatorial, circumferential ring (arrow labeled
C) with aberrantly placed grooves (unlabeled arrows) formed in response
to vancomycin. Arrows labeled P indicate nearly parallel grooves formed
in one cell. Scanning area, 1.5 by 1.5 µm.
|
|
When grown on medium containing a subinhibitory concentration of
vancomycin (1 µg/ml), vancomycin-susceptible control strains RN4220
and 6/3 8N often produced cells with additional grooves or rings which
either were nearly parallel (referred to hereafter as parallel) or
intersected the primary ring at various angles (Fig. 2c). In contrast,
untreated cells of strain NJ (Fig. 3a) produced a pair of circumferential rings arranged in parallel. Revertant strain NJ[P15] also had the parallel, dual-ring topology (Fig. 3b). When strain NJ was grown in the presence of a subinhibitory concentration of vancomycin (7 µg/ml) (Fig. 3c and e), the cells maintained the parallel dual-ring topology. In contrast, vancomycin at
3 µg/ml induced cells of strain NJ[P15] to produce a third ring
(Fig. 3d and f) that was parallel to the two primary circumferential rings seen on untreated cocci. Interestingly, although colonial growth
of strain NJ[P15] did not arise on BHIA containing 7 µg of
vancomycin/ml, cells did grow in small, flat, patchy films on the agar
surface. Interestingly, cells from this film also produced three rings,
identical to those of cells that produced colonies at 3 µg of
vancomycin/ml.

View larger version (114K):
[in this window]
[in a new window]
|
FIG. 3.
AFM images of cells from GISA clinical strain NJ and
related revertant strain NJ[P15] showing parallel rings traversing
each cell. Panels: a, GISA strain NJ; b, revertant strain NJ[P15]; c,
vancomycin (7 µg/ml)-treated cells of strain NJ; d, vancomycin (3 µg/ml)-treated cells of strain NJ[P15]; e, closer-range view of the
cell labeled e in panel c; f, closer-range view of the cell labeled f
in panel d. The arrows in panels e and f point to nearly parallel
rings. The scanning area used to obtain the images in panels a to d was
3 by 3 µm. The scanning area used to obtain the images shown in
panels e and f was 1 by 1 µm.
|
|
The depth of the circumferential rings was the characteristic that best
distinguished the resistant from the susceptible strains. When cells
were grown in the absence of vancomycin, the grooves that formed the
rings on cells of strain NJ were shallower than those of cells of the
three vancomycin-susceptible strains examined (Table
1). The grooves deepened on cells of all
of the strains when they were grown in the presence of vancomycin
(Table 1); however, the increase was slightly more pronounced for the
susceptible revertant strain (4.5-fold increase) than for the resistant
parent (3.4-fold).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Mean depths of circumferential rings observed in
vancomycin-susceptible strains and GISA clinical
strain NJa
|
|
The two parallel rings on untreataed cells from strain NJ were
separated by a narrower gap (164 ± 13.4 nm, mean gap width ± the
standard deviation) than that between parallel rings on untreated cells
from the revertant strain NJ[P15] (190 ± 19 nm). The mean width of
the gap between parallel rings of strain NJ grown in the presence of 7 µg of vancomycin/ml was 167 ± 10 nm. Thus, vancomycin did not
considerably affect the distance between the rings of cells of the
resistant strain. For the revertant strain NJ[P15] grown in the
presence of vancomycin (3 µg/ml), the three parallel rings were
separated by two consecutive gaps with mean widths of 198 ± 17 nm
(large gap) and 169 ± 15 nm (small gap). Thus, the width of the large
interring gap on vancomysin-treated cells of strain NJ[P15]
corresponds to that found between the two rings of the untreated cells
of this strain.
To summarize, as shown in the schematic in Fig.
4, one equatorial ring was present on
cells from the vancomycin-susceptible strains, whereas a dual-ring
structure characterized the cell surface of GISA strain NJ. The
dual-ring topography of strain NJ is not associated with the
methicillin resistance phenotype of the isolate, since cells of the
vancomycin-susceptible, methicillin-resistant control strain had only
one ring. Strain NJ had the shallowest ring depth of the four strains
examined, and only vancomycin-resistant strain NJ was resistant to
further ring or groove formation in the presence of vancomycin.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic illustrating patterns of rings and grooves in
untreated and vancomycin-treated S. aureus strains.
Vancomycin-susceptible S. aureus (VSSA) control strains
produced a single circumferential ring in untreated cells, and
additional grooves or rings with various orientations were present in
vancomycin (1 µg/ml)-treated control cells. Untreated cells of the
GISA strain NJ (GISA) and the revertant isolate had two parallel rings.
Vancomycin (7 µg/ml)-treated cells of the GISA strain had the same
appearance as untreated cells. Vancomycin (3 µg/ml)-treated cells of
the revertant strain produced a third ring. Note that the two adjacent
gaps between rings on the vancomycin-treated revertant strain are
unequal in size.
|
|
From these data, we can envision that the susceptible progenitor of
strain NJ formed additional grooves when exposed to vancomycin and that
cells with the parallel dual-ring structure had a selective advantage
in the presence of vancomycin. The dual-ring structure of the revertant
form of strain NJ was apparently inherited from the resistant parent
strain, and reversion was likely obtained through a pathway that
utilized a second-site mutation that did not abolish formation of the
second ring. At present, however, it is difficult to assess whether or
not these observations represent a general phenomenon that occurs in
all GISA strains.
The circumferential ring seen by AFM imaging is likely the site of the
bacterial septum. Septum formation is a complex process requiring the
coordinated targeting of a number of cell division proteins
(16). We can speculate that the second equatorial ring of
strain NJ was formed by aberrant targeting of S. aureus cell division proteins that are normally arranged at the cell surface in one
equatorial ring (1, 10, 17, 27). Alternately, the dual rings
can be explained by thickening of cross walls. The latter explanation
is unlikely since evidence for uniform cross wall thickening in this
strain is lacking from our transmission electron microscopic images of
thin sections (unpublished data).
In conclusion, the fine structural detail provided by AFM has extended
previous topographic studies of vancomycin-susceptible (8)
and vancomycin-resistant S. aureus (7, 8, 13,
19-22) by showing novel morphological changes occurring in the
cell surface in untreated, as well as vancomycin-treated, staphylococci.
 |
ACKNOWLEDGMENTS |
We are grateful to Fred Tenover from the Centers for Disease
Control and Prevention for providing the NJ GISA isolate.
This work was supported by NIAID grants RO3 1 AI 44999-0 and RO1
AI40481-01A1 and a grant from the Grant Healthcare Foundation (Lake
Forest, Ill.). This work was also supported by the NSF-Materials Research Science and Engineering Center at The University of Chicago (DMR-9808595).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pediatrics, The University of Chicago MC 6054, 5841 S. Maryland Ave., Chicago, IL 60637. Phone: (773) 702-6401. Fax: (773) 702-1196. E-mail: sboyleva{at}midway.uchicago.edu.
 |
REFERENCES |
| 1.
|
Baba, T., and O. Schneewind.
1998.
Targeting of muralytic enzymes to the cell division site of Gram-positive bacteria: repeat domains direct autolysin to the equatorial surface ring of Staphylococcus aureus.
EMBO J.
17:4639-4646[CrossRef][Medline].
|
| 1a.
|
Barna, J. C. J., and D. H. Williams.
1984.
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
Annu. Rev. Microbiol.
38:339-357[CrossRef][Medline].
|
| 2.
|
Boyle-Vavra, S.,
S. K. Berke,
J. C. Lee, and R. S. Daum.
2000.
Reversion of glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.
Antimicrob. Agents Chemother.
44:272-277[Abstract/Free Full Text].
|
| 3.
|
Braga, P. C., and D. Ricci.
1998.
Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime.
Antimicrob Agents Chemother.
42:18-22[Abstract/Free Full Text].
|
| 4.
|
Braga, P. C., and D. Ricci.
2000.
Detection of rokitamycin-induced morphostructural alterations in Helicobacter pylori by atomic force microscopy.
Chemotherapy
46:15-22[Medline].
|
| 5.
|
Centers for Disease Control and Prevention.
1997.
Staphylococcus aureus with reduced susceptibility to vancomycin United States, 1997.
Morbid. Mortal. Weekly Rep.
46:765-766[Medline].
|
| 6.
|
Centers for Disease Control and Prevention.
1997.
Update: Staphylococcus aureus with reduced susceptibility to vancomycin United States, Sept. 1997.
Morbid. Mortal. Weekly Rep.
46:813-815[Medline].
|
| 7.
|
Daum, R. S.,
S. Gupta,
R. Sabbagh, and W. M. Milewski.
1992.
Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility.
J. Infect. Dis.
166:1066-1072[Medline].
|
| 8.
|
Filice, G.,
P. Lanzarini,
P. Orsolini,
L. Soldini,
L. Perversi,
G. Carnevale,
G. Comolli, and F. Castelli.
1990.
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure.
Microbiologica
13:231-237[Medline].
|
| 9.
|
Giesbrecht, P.,
H. Labischinski, and J. Wecke.
1985.
A special morphogenetic wall defect and the subsequent activity of "murosomes" as the very reason for penicillin-induced bacteriolysis in staphylococci.
Arch. Microbiol.
141:315-324[CrossRef][Medline].
|
| 10.
|
Giesbrecht, P.,
J. Wecke, and B. Reinicke.
1976.
On the morphogenesis of the cell wall of staphylococci.
Int. Rev. Cytol.
44:225-318[Medline].
|
| 11.
|
Hahm, J.,
W. Lopes,
H. Jaeger, and S. Sibener.
1998.
Defect evolution in ultrathin films of polystyrene-block-polymethylmethacrylate diblock copolymers observed by atomic force microscopy.
J. Chem. Physics
109:10111-10114[CrossRef].
|
| 12.
|
Hahm, J., and S. Sibener.
2000.
Cylinder alignment in annular structures of microphase-separated polystyrene- -poly(methylmethacrylate).
Langmuir
16:4766-4769[CrossRef].
|
| 13.
|
Hanaki, H.,
K. Kuwahara-Arai,
S. Boyle-Vavra,
R. S. Daum,
H. Labischinski, and K. Hiramatsu.
1998.
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
J. Antimicrob. Chemother.
42:199-209[Abstract/Free Full Text].
|
| 14.
|
Kreiswirth, B. N.,
S. Lofdahl,
M. J. Betley,
M. O'Reilly,
P. M. Schlievert,
M. S. Bergdoll, and R. P. Novick.
1983.
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.
Nature
305:709-712[CrossRef][Medline].
|
| 15.
|
Lal, R., and S. A. John.
1994.
Biological applications of atomic force microscopy.
Am. J. Physiol.
266:C1-C21[Abstract/Free Full Text].
|
| 16.
|
Lutkenhaus, J.
1998.
The regulation of bacterial cell division: a time and place for it.
Curr. Opin. Microbiol.
1:210-215[CrossRef][Medline].
|
| 17.
|
Lutkenhaus, J., and S. G. Addinall.
1997.
Bacterial cell division and the Z ring.
Annu. Rev. Biochem.
66:93-116[CrossRef][Medline].
|
| 18.
|
National Committee for Clinical Laboratory Standards.
1999.
Performance standards for antimicrobial susceptibility testing, ninth informational supplement M100-S9, vol. 19.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 19.
|
Pfeltz, R. F.,
V. K. Singh,
J. L. Schmidt,
M. A. Batten,
C. S. Baranyk,
M. J. Nadakavukaren,
R. K. Jayaswal, and B. J. Wilkinson.
2000.
Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
Antimicrob. Agents Chemother.
44:294-303[Abstract/Free Full Text].
|
| 20.
|
Sieradzki, K.,
R. B. Roberts,
S. W. Haber, and A. Tomasz.
1999.
The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
N. Engl. J. Med.
340:517-523[Free Full Text].
|
| 21.
|
Sieradzki, K., and A. Tomasz.
1996.
A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus.
FEMS Microbiol. Lett.
142:161-166[CrossRef][Medline].
|
| 22.
|
Sieradzki, K., and A. Tomasz.
1997.
Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.
J. Bacteriol.
179:2557-2566[Abstract/Free Full Text].
|
| 23.
|
Smith, T. L.,
M. L. Pearson,
K. R. Wilcox,
C. Cruz,
M. V. Lancaster,
B. Robinson-Dunn,
F. Tenover,
M. J. Zervos,
J. D. Band,
E. White, and W. R. Jarvis.
1999.
Emergence of vancomycin resistance in Staphylococcus aureus.
N. Engl. J. Med.
340:493-501[Abstract/Free Full Text].
|
| 24.
|
Suggs, A. H.,
M. C. Maranan,
S. Boyle-Vavra, and R. S. Daum.
1999.
Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors.
Pediatr. Infect. Dis. J.
18:410-414[CrossRef][Medline].
|
| 25.
|
Tenover, F. C.
1999.
Implications of vancomycin-resistant Staphylococcus aureus.
J. Hosp. Infect.
43(Suppl.):S3-S7.
|
| 26.
|
Umeda, A.,
M. Saito, and K. Amako.
1998.
Surface characteristics of gram-negative and gram-positive bacteria in an atomic force microscope image.
Microbiol. Immunol.
42:159-164[Medline].
|
| 27.
|
Yamada, S.,
M. Sugai,
H. Komatsuzawa,
S. Nakashima,
T. Oshida,
A. Matsumoto, and H. Suginaka.
1996.
An autolysin ring associated with cell separation of Staphylococcus aureus.
J. Bacteriol.
178:1565-1571[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, December 2000, p. 3456-3460, Vol. 44, No. 12
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.